Biofil Chemicals and Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Biofil Chemicals and Pharmaceuticals has a total shareholder equity of ₹184.0M and total debt of ₹4.6M, which brings its debt-to-equity ratio to 2.5%. Its total assets and total liabilities are ₹420.4M and ₹236.4M respectively. Biofil Chemicals and Pharmaceuticals's EBIT is ₹6.8M making its interest coverage ratio 21.4. It has cash and short-term investments of ₹2.2M.
Key information
2.5%
Debt to equity ratio
₹4.55m
Debt
| Interest coverage ratio | 21.4x |
| Cash | ₹2.20m |
| Equity | ₹183.97m |
| Total liabilities | ₹236.44m |
| Total assets | ₹420.40m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 524396's short term assets (₹336.1M) exceed its short term liabilities (₹232.9M).
Long Term Liabilities: 524396's short term assets (₹336.1M) exceed its long term liabilities (₹3.6M).
Debt to Equity History and Analysis
Debt Level: 524396's net debt to equity ratio (1.3%) is considered satisfactory.
Reducing Debt: 524396's debt to equity ratio has reduced from 9.9% to 2.5% over the past 5 years.
Debt Coverage: 524396's debt is well covered by operating cash flow (73.6%).
Interest Coverage: 524396's interest payments on its debt are well covered by EBIT (21.4x coverage).